Want to see TSE:PRN full AI Analyst Report?
Total Valuation
Profound Medical has a market cap or net worth of C$372.63M. The enterprise value is C$298.96.
Market CapC$372.63M
Enterprise ValueC$298.96
Share Statistics
Profound Medical has 36,532,593 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,532,593
Owned by Insiders2.95%
Owned by Institutions15.95%
Financial Efficiency
Profound Medical’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -31.10%.
Return on Equity (ROE)-0.65
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-31.10%
Return on Capital Employed (ROCE)-0.31
Revenue Per Employee101.11K
Profits Per Employee-262.78K
Employee Count162
Asset Turnover0.12
Inventory Turnover0.58
Valuation Ratios
The current PE Ratio of Profound Medical is ―. Profound Medical’s PEG ratio is -0.20.
PE Ratio―
PS Ratio14.48
PB Ratio3.58
Price to Fair Value3.58
Price to FCF-6.07
Price to Operating Cash Flow-7.14
PEG Ratio-0.20
Income Statement
In the last 12 months, Profound Medical had revenue of 16.38M and earned -43.32M in profits. Earnings per share was -1.43.
Revenue16.38M
Gross Profit11.59M
Operating Income-41.98M
Pretax Income-43.06M
Net Income-43.32M
EBITDA-41.41M
Earnings Per Share (EPS)-1.43
Cash Flow
In the last 12 months, operating cash flow was -35.61M and capital expenditures -179.09K, giving a free cash flow of -35.79M billion.
Operating Cash Flow-35.61M
Free Cash Flow-35.79M
Free Cash Flow per Share-0.98
Dividends & Yields
Profound Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.58
52-Week Price Change26.17%
50-Day Moving Average9.82
200-Day Moving Average9.46
Relative Strength Index (RSI)44.45
Average Volume (3m)24.45K
Important Dates
Profound Medical upcoming earnings date is Oct 29, 2026, After Close (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateOct 29, 2026
Ex-Dividend Date―
Financial Position
Profound Medical as a current ratio of 12.52, with Debt / Equity ratio of 14.82%
Current Ratio12.52
Quick Ratio11.17
Debt to Market Cap0.02
Net Debt to EBITDA1.33
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Profound Medical has paid 256.41K in taxes.
Income Tax256.41K
Effective Tax Rate>-0.01
Enterprise Valuation
Profound Medical EV to EBITDA ratio is -4.40, with an EV/FCF ratio of -4.67.
EV to Sales11.12
EV to EBITDA-4.40
EV to Free Cash Flow-4.67
EV to Operating Cash Flow-4.69
Balance Sheet
Profound Medical has C$38.21M in cash and marketable securities with C$7.37M in debt, giving a net cash position of C$30.84M billion.
Cash & Marketable SecuritiesC$38.21M
Total DebtC$7.37M
Net CashC$30.84M
Net Cash Per ShareC$0.84
Tangible Book Value Per ShareC$2.19
Margins
Gross margin is 71.73%, with operating margin of -256.27%, and net profit margin of -264.44%.
Gross Margin71.73%
Operating Margin-256.27%
Pretax Margin-262.88%
Net Profit Margin-264.44%
EBITDA Margin-252.79%
EBIT Margin-256.27%
Analyst Forecast
The average price target for Profound Medical is C$15.35, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetC$15.35
Price Target Upside49.30% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast59.60%
EPS Growth Forecast32.53%